SEC Form 4 · accession 0001171843-15-003259
Sucampo Pharmaceuticals, Inc. · SCMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barbara A Munder
Director
Period of report
May 29, 2015
Accepted (ET)
Jun 2, 2015 · 5:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001365216
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F1 | $16.23 | May 29, 2015 | A | 20,000 | A | — | May 29, 2025 | Class A Common Stock | 20,000 | 90,000 | D |
Explanation of responses
- F1Vesting commences June 29, 2015 in 12 equal monthly installments.